GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - ...
Treatment of Parkinson's disease is in large part based on the administration of levodopa. The use of this drug is limited by ...
JP Morgan upgrades Amneal Pharmaceuticals, citing strong Crexont sales, robust generics growth, and a higher 2025 revenue forecast, with peak sales over $300 million.
Celon Pharma’s PDE10A inhibitor has reduced involuntary movements in a phase 2 trial of individuals with Parkinson’s disease.
Polish drugmaker Celon Pharma (WSE: CLN) has announced positive results from a Phase II trial of CPL’36, an experimental oral ...
AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
Further information Decision makers have concluded that the clear rationale to not evaluate this product is due to it being a change to the formulation of an existing product as per section 7.1.3 of ...
Find all the commercial and brand names of generic drug called Levodopa. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...
GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and ...
Find all the commercial and brand names of generic drug called Carbidopa-Levodopa . This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results